Effect of antibiotic pretreatment on immunogenicity of human heart valves and component cells

Annals of Thoracic Surgery

Volumn 66, Issue 6 SUPPL., 1998, Pages

  Johnson, Delia L ^a   Sloan, Cathryn ^a   O'Halloran, Angela ^a   Yacoub, Magdi H ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIBIOTIC AGENT; CARBENICILLIN; CD4 ANTIGEN; CEFOTAXIME; COLISTIN; GAMMA INTERFERON; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; THYMIDINE; TRITIUM;

ANTIBIOTIC THERAPY; AORTA VALVE; CELL PROLIFERATION; COCULTURE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTI-BACTERIAL AGENTS; AORTIC VALVE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RADIOPHARMACEUTICALS; STERILIZATION; T-LYMPHOCYTES; THYMIDINE; TRANSPLANTATION IMMUNOLOGY; TRITIUM;

EID: 0032459674     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)01033-9     Document Type: Conference Paper

References (13)

1. Yacoub M., Rasmi N.R.H., Sundt T.M., et al. A fourteen-year experience with homovital homografts for aortic-valve replacement. J Thorac Cardiovasc Surg. 110:1995;185-194.
2. O'Brien M.F., Stafford E.G., Gardner M.A.H., et al. Allograft aortic valve replacement long-term follow-up . Ann Thorac Surg. 60:1995;S65-S70.
3. Clarke D.R., Campbell D.N., Hayward A.R., Bishop D.A. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg. 105:1993;934-942.
4. Yankah A.C., Alexi-Meskhishvili V., Weng Y., Schorn K., Lange P.E., Hetzer R. Accelerated degeneration of allografts in the first two years of life. Ann Thorac Surg. 60:1995;S71-S77.
5. Smith J.D., Ogino H., Hunt D., Laylor R.M., Rose M.L., Yacoub M.H. Humoral immune response to human aortic valve homografts. Ann Thorac Surg. 60:1995;S127-S130.
6. Hoekstra M.D., Knoop C., Vaessen L., et al. Donor-specific cellular immune response against human cardiac valve. J Thorac Cardiovasc Surg. 112:1996;281-286.
7. Hogan P., Duplock L., Green M., et al. Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg. 112:1996;1260-1267.
8. Johnson D.L., Rose M.L., Yacoub M.H. Immunogenicity of human heart valve endothelial cells and fibroblasts. Transplant Proc. 29:1997;984-985.
9. Simon A., Zavazava N., Sievers H.H., Muller-Ruchholtz W. In vitro cultivation and immunogenicity of human cardiac valve endothelium. J Card Surg. 8:1993;656-665.
10. Hoekstra F., Knoop C., Jutte N., et al. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Tranplant. 13:1994;1095-1098.
11. McDouall R.M., Page C.S., Hafizi S., Yacoub M.H., Rose M.L. Alloproliferation of purified CD4+ T cells to adult human heart endothelial cells and study of second signal requirements. Immunology. 89:1996;220-226.
12. Masur S.K., Dewal H.S., Dinh T.T., Erenburg I., Petridou S. Myofibroblasts differentiate from fibroblasts when plated out at low density. Proc Natl Acad Sci USA. 94:1996;4219-4223.
13. Glimcher L.H., Kara C.J. Sequences and factors a guide to MHC class II transcription . Annu Rev Immunol. 10:1992;13-49.